Skip to main content
Top
Published in: Journal of Medical Ultrasonics 4/2018

01-10-2018 | Original Article

A novel ultrasonic method for evaluation of blood clotting parameters

Authors: Vacis Tatarunas, Algirdas Voleisis, Reimondas Sliteris, Rymantas Kazys, Liudas Mazeika, Vaiva Lesauskaite

Published in: Journal of Medical Ultrasonics | Issue 4/2018

Login to get access

Abstract

Purpose

For long time, blood clot retraction was measured only by thromboelastographic or platelet contractile force measurement techniques. The purpose of the present study was development of a novel ultrasonic method based on simultaneous monitoring of variations in the ultrasound velocity and the frequency spectrum of the signal propagating in clotting blood and its application for automatic evaluation of blood clotting parameters.

Methods

Simultaneous measurement of ultrasound velocity and variations in the frequency spectrum of wideband ultrasonic signals in clotting blood samples was performed. All measurements were performed in pulse-echo mode. Standard clinical data were obtained using routine clinical laboratory methods.

Results

The amplitudes of ultrasonic signals during native blood coagulation varied up to ten times for different frequencies. The measurement results of the start and duration of blood clot retraction differed between patient samples: different components of the blood coagulation system had significant impact on the blood clot retraction process.

Conclusions

Our results showed that during blood clotting, the ultrasound velocity and variations in frequency spectrum should be used simultaneously to determine the beginning and duration of blood clot retraction. Our results also showed that blood clot retraction is controlled by the activity of factor XIII.
Literature
1.
go back to reference Townsend N, Nichols M, Scarborough P, et al. Cardiovascular disease in Europe—epidemiological update 2015. Eur Heart J. 2015;36:2696–705.CrossRef Townsend N, Nichols M, Scarborough P, et al. Cardiovascular disease in Europe—epidemiological update 2015. Eur Heart J. 2015;36:2696–705.CrossRef
2.
go back to reference Weisel JW, Litvinov RI. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013;121:1712–9.CrossRef Weisel JW, Litvinov RI. Mechanisms of fibrin polymerization and clinical implications. Blood. 2013;121:1712–9.CrossRef
3.
go back to reference Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRef Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRef
4.
go back to reference Schmidt H, Schmidt R, Niederkorn K, et al. Beta-fibrinogen gene polymorphism (C148– > T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol. 1998;18:487–92.CrossRef Schmidt H, Schmidt R, Niederkorn K, et al. Beta-fibrinogen gene polymorphism (C148– > T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol. 1998;18:487–92.CrossRef
5.
go back to reference Chen X, Xu M, Jin L, Chen J, Chen W. Association of beta-fibrinogen gene -148C/T and -455G/A polymorphisms and coronary artery disease in Chinese population: a meta analysis. Sci China C Life Sci. 2008;51:814–20.CrossRef Chen X, Xu M, Jin L, Chen J, Chen W. Association of beta-fibrinogen gene -148C/T and -455G/A polymorphisms and coronary artery disease in Chinese population: a meta analysis. Sci China C Life Sci. 2008;51:814–20.CrossRef
6.
go back to reference Theodoraki EV, Nikopensius T, Suhorutsenko J, et al. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study. BMC Med Genet. 2010;11:28.CrossRef Theodoraki EV, Nikopensius T, Suhorutsenko J, et al. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study. BMC Med Genet. 2010;11:28.CrossRef
7.
go back to reference Kreutz RP, Bitar A, Owens J, et al. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease. J Thromb Thrombolysis. 2014;38:380–7.CrossRef Kreutz RP, Bitar A, Owens J, et al. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease. J Thromb Thrombolysis. 2014;38:380–7.CrossRef
8.
go back to reference Kucharska-Newton AM, Monda KL, Campbell S, et al. Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2011;216:151–6.CrossRef Kucharska-Newton AM, Monda KL, Campbell S, et al. Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2011;216:151–6.CrossRef
9.
go back to reference Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia. 2008;14:1190–200.CrossRef Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia. 2008;14:1190–200.CrossRef
10.
go back to reference Liang XM, Han SJ, Reems JA, et al. Platelet retraction force measurements using flexible post force sensors. Lab Chip. 2010;10:991–8.CrossRef Liang XM, Han SJ, Reems JA, et al. Platelet retraction force measurements using flexible post force sensors. Lab Chip. 2010;10:991–8.CrossRef
11.
go back to reference Smyth SS, Whiteheart S, Italiano JE, Coller BS (2010) Chapter 114. In: Platelet morphology, biochemistry, and function. Prchal JT, Kaushansky K, Lichtman MA, Kipps TJ, Seligsohn U (eds) Williams hematology, 8th edn. New York: McGraw-Hill 22. Smyth SS, Whiteheart S, Italiano JE, Coller BS (2010) Chapter 114. In: Platelet morphology, biochemistry, and function. Prchal JT, Kaushansky K, Lichtman MA, Kipps TJ, Seligsohn U (eds) Williams hematology, 8th edn. New York: McGraw-Hill 22.
12.
go back to reference Huang CC, Lin YH, Liu TY, et al. Review: study of the blood coagulation by ultrasound. J Med Biol Eng. 2011;31:79–86.CrossRef Huang CC, Lin YH, Liu TY, et al. Review: study of the blood coagulation by ultrasound. J Med Biol Eng. 2011;31:79–86.CrossRef
13.
go back to reference Huang CC, Wang SH, Tsui PH. Detection of blood coagulation and clot formation using quantitative ultrasonic parameters. Ultrasound Med Biol. 2005;31:1567–73.CrossRef Huang CC, Wang SH, Tsui PH. Detection of blood coagulation and clot formation using quantitative ultrasonic parameters. Ultrasound Med Biol. 2005;31:1567–73.CrossRef
14.
go back to reference Shung KK, Fei DY, Yuan YW, et al. Ultrasonic characterization of blood during coagulation. J Clin Ultrasound. 1984;12:147–53.CrossRef Shung KK, Fei DY, Yuan YW, et al. Ultrasonic characterization of blood during coagulation. J Clin Ultrasound. 1984;12:147–53.CrossRef
15.
go back to reference Machado JC, von Kruger MA, Fontes EM, et al. Evaluation of an ultrasonic method applied to the measurement of blood coagulation time. Physiol Meas. 1997;18:129–43.CrossRef Machado JC, von Kruger MA, Fontes EM, et al. Evaluation of an ultrasonic method applied to the measurement of blood coagulation time. Physiol Meas. 1997;18:129–43.CrossRef
16.
go back to reference Libgot-Callé R, Ossant F, Gruel Y, et al. High frequency ultrasound device to investigate the acoustic properties of whole blood during coagulation. Ultrasound Med Biol. 2008;34:252–64.CrossRef Libgot-Callé R, Ossant F, Gruel Y, et al. High frequency ultrasound device to investigate the acoustic properties of whole blood during coagulation. Ultrasound Med Biol. 2008;34:252–64.CrossRef
17.
go back to reference Callé R, Plag C, Patat F, et al. Interest of the attenuation coefficient in multiparametric high frequency ultrasound investigation of whole blood coagulation process. J Acoust Soc Am. 2009;125:530–8.CrossRef Callé R, Plag C, Patat F, et al. Interest of the attenuation coefficient in multiparametric high frequency ultrasound investigation of whole blood coagulation process. J Acoust Soc Am. 2009;125:530–8.CrossRef
18.
go back to reference Callé R, Rochefort GY, Desbuards N, et al. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model. Ultrasound Med Biol. 2010;36:295–305.CrossRef Callé R, Rochefort GY, Desbuards N, et al. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model. Ultrasound Med Biol. 2010;36:295–305.CrossRef
19.
go back to reference Cloutier G, Qin Z. Ultrasound backscattering from non-aggregating and aggregating erythrocytes—a review. Biorheology. 1997;34:443–70.CrossRef Cloutier G, Qin Z. Ultrasound backscattering from non-aggregating and aggregating erythrocytes—a review. Biorheology. 1997;34:443–70.CrossRef
20.
go back to reference Shih CC, Liu TY, Huang CC. In vitro assessments of viscoelastic properties of fibrin clot by using acoustic radiation force on a solid sphere. In: Ultrasonics symposium (IUS), 2010 IEEE. IEEE, 2010. pp 479–482. Shih CC, Liu TY, Huang CC. In vitro assessments of viscoelastic properties of fibrin clot by using acoustic radiation force on a solid sphere. In: Ultrasonics symposium (IUS), 2010 IEEE. IEEE, 2010. pp 479–482.
21.
go back to reference Grybauskas P, Kundrotas K, Sukackas V, et al. Ultrasonic digital interferometer for investigation of blood clotting. Ultrasonics. 1978;16:33–6.CrossRef Grybauskas P, Kundrotas K, Sukackas V, et al. Ultrasonic digital interferometer for investigation of blood clotting. Ultrasonics. 1978;16:33–6.CrossRef
22.
go back to reference Voleisis A, Kazys R, Mazeika L, et al. Ultrasonic method for the whole blood coagulation analysis. Ultrasonics. 2002;40:101–7.CrossRef Voleisis A, Kazys R, Mazeika L, et al. Ultrasonic method for the whole blood coagulation analysis. Ultrasonics. 2002;40:101–7.CrossRef
23.
go back to reference Del Grosso VA, Mader CW. Speed of sound in pure water. J Acoust Soc Am. 1972;52:1442–6.CrossRef Del Grosso VA, Mader CW. Speed of sound in pure water. J Acoust Soc Am. 1972;52:1442–6.CrossRef
24.
go back to reference Tatarunas V, Jankauskiene L, Kupstyte N, et al. The role of clinical parameters and of CYP2C19 G681 and CYP4F2 G1347A polymorphisms on platelet reactivity during dual antiplatelet therapy. Blood Coagul Fibrinolysis. 2014;25:369–74.CrossRef Tatarunas V, Jankauskiene L, Kupstyte N, et al. The role of clinical parameters and of CYP2C19 G681 and CYP4F2 G1347A polymorphisms on platelet reactivity during dual antiplatelet therapy. Blood Coagul Fibrinolysis. 2014;25:369–74.CrossRef
25.
go back to reference Undas A, Brzezinska-Kolarz B, Brummel-Ziedins K, et al. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects. J Thromb Haemost. 2005;3:2015–21.CrossRef Undas A, Brzezinska-Kolarz B, Brummel-Ziedins K, et al. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects. J Thromb Haemost. 2005;3:2015–21.CrossRef
26.
go back to reference Floyd CN, Ellis BH, Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis. PLoS ONE. 2014;9:e100239.CrossRef Floyd CN, Ellis BH, Ferro A. The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis. PLoS ONE. 2014;9:e100239.CrossRef
27.
go back to reference Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation. 2000;101:1013–8.CrossRef Michelson AD, Furman MI, Goldschmidt-Clermont P, et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation. 2000;101:1013–8.CrossRef
28.
go back to reference Balogh I, Szôke G, Kárpáti L, et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood. 2000;96:2479–86.PubMed Balogh I, Szôke G, Kárpáti L, et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood. 2000;96:2479–86.PubMed
29.
go back to reference van Loon JE, de Maat MP, Deckers JW, et al. Prognostic markers in young patients with premature coronary heart disease. Atherosclerosis. 2012;224:213–7.CrossRef van Loon JE, de Maat MP, Deckers JW, et al. Prognostic markers in young patients with premature coronary heart disease. Atherosclerosis. 2012;224:213–7.CrossRef
30.
go back to reference Wypasek E, Stepien E, Kot M, et al. Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting. Inflammation. 2012;35:429–35.CrossRef Wypasek E, Stepien E, Kot M, et al. Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting. Inflammation. 2012;35:429–35.CrossRef
Metadata
Title
A novel ultrasonic method for evaluation of blood clotting parameters
Authors
Vacis Tatarunas
Algirdas Voleisis
Reimondas Sliteris
Rymantas Kazys
Liudas Mazeika
Vaiva Lesauskaite
Publication date
01-10-2018
Publisher
Springer Singapore
Published in
Journal of Medical Ultrasonics / Issue 4/2018
Print ISSN: 1346-4523
Electronic ISSN: 1613-2254
DOI
https://doi.org/10.1007/s10396-018-0874-1

Other articles of this Issue 4/2018

Journal of Medical Ultrasonics 4/2018 Go to the issue

Editor's Note

Editor’s note